← Back to Search

Pharmacist-Assisted Medication Transition for Care Transitions

N/A

Recruiting

Led By Giana Davidson, MD, MPH

Research Sponsored by University of Washington

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

18 years of age and older

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up through intervention completion, around 3 years

Awards & highlights

Study Summary

This trial evaluates whether having a pharmacist help with a patient's transition from hospital to SNF decreases the number of medication-related problems.

Who is the study for?

This trial is for adults over 18 transitioning from certain hospitals to independent skilled nursing facilities. It's not for those under 18 or patients moving to hospice care.Check my eligibility

What is being tested?

The study tests a Pharmacy Integrated Transitions program where a clinical pharmacist helps manage medication during the move from hospital to skilled nursing facility, using a crossover randomized control design.See study design

What are the potential side effects?

Since this trial focuses on medication management and structured hand-offs rather than new medications, side effects are not the main concern but may include issues related to potential mishandling of medications.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am 18 years old or older.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ through intervention completion, around 3 years

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~through intervention completion, around 3 years

This trial's timeline: 3 weeks for screening, Varies for treatment, and through intervention completion, around 3 years for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Medication Related Problems

Secondary outcome measures

Death

Fidelity of intervention

Readmissions

Side effects data

From 2022 Phase 4 trial • 494 Patients • NCT03688100

17%

All-Cause Mortality

100%

80%

60%

40%

20%

Study treatment Arm

Patients: Medication Management (MEDS)

Patients: Behavioral Activation Therapy (BA)

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: Clinical Pharmacist in Transition of CareExperimental Treatment2 Interventions

A clinical pharmacist will be provided as a patient discharges from one of four University of Washington (UW) medical centers to a skilled nursing facility randomized to the intervention arm. Pharmacist will perform additional clinical review and communication tasks with hospital and SNF clinical staff.

Group II: Patient transitions from hospital to post-acute careActive Control1 Intervention

Patient will transition from one of four University of Washington (UW) medical centers to a skilled nursing facility randomized to the control arm. Patients will receive the standard discharge process.

0 / 1Eligibility criteria met

Find a Location

Who is running the clinical trial?

University of WashingtonLead Sponsor

1,738 Previous Clinical Trials

1,838,591 Total Patients Enrolled

Agency for Healthcare Research and Quality (AHRQ)FED

399 Previous Clinical Trials

6,816,588 Total Patients Enrolled

2 Trials studying Transition Care

467 Patients Enrolled for Transition Care

Giana Davidson, MD, MPHPrincipal InvestigatorUniversity of Washington

2 Previous Clinical Trials

3,418 Total Patients Enrolled

Media Library

Pharmacy Integrated Transitions (PIT) program Clinical Trial Eligibility Overview. Trial Name: NCT05241951 — N/A

Transition Care Research Study Groups: Clinical Pharmacist in Transition of Care, Patient transitions from hospital to post-acute care

Transition Care Clinical Trial 2023: Pharmacy Integrated Transitions (PIT) program Highlights & Side Effects. Trial Name: NCT05241951 — N/A

Pharmacy Integrated Transitions (PIT) program 2023 Treatment Timeline for Medical Study. Trial Name: NCT05241951 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any available slots left for participation in this research?

"Affirmative. Data on clinicaltrials.gov reveals that this scientific investigation, which was publicized on the 31st of January 2022, is actively seeking patients. 5760 individuals have to be enrolled from a single medical facility."

Answered by AI

How many individuals are involved in this experimental program?

"Affirmative. According to information on clinicaltrials.gov, this medical experiment is still accepting patients at the present moment. It was initially publicised on January 31st 2022 and modified most recently on February 11th 2022; 5760 participants are needed from 1 research site."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Preventing Medication-Related Problems in Care Transitions to Skilled Nursing Facilities

Giana Davidson 2022. "Preventing Medication-Related Problems in Care Transitions to Skilled Nursing Facilities". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05241951.